ZELLI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.189
EU - Europa 1.224
AS - Asia 1.021
SA - Sud America 254
AF - Africa 35
OC - Oceania 4
Totale 4.727
Nazione #
US - Stati Uniti d'America 2.154
SG - Singapore 492
RU - Federazione Russa 396
IE - Irlanda 237
BR - Brasile 215
HK - Hong Kong 154
IT - Italia 151
DE - Germania 148
VN - Vietnam 137
CN - Cina 128
FI - Finlandia 73
GB - Regno Unito 36
SE - Svezia 32
FR - Francia 29
IN - India 25
CZ - Repubblica Ceca 24
JP - Giappone 19
PL - Polonia 18
ZA - Sudafrica 18
ES - Italia 17
CA - Canada 15
BE - Belgio 14
AR - Argentina 12
MX - Messico 12
UA - Ucraina 10
EC - Ecuador 9
BD - Bangladesh 8
VE - Venezuela 8
IQ - Iraq 7
NL - Olanda 7
ID - Indonesia 6
TR - Turchia 6
UY - Uruguay 6
KR - Corea 5
AT - Austria 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
PH - Filippine 3
BA - Bosnia-Erzegovina 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PK - Pakistan 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
Totale 4.727
Città #
Dallas 416
Singapore 281
San Jose 274
Dublin 235
Chandler 233
Ashburn 194
Hong Kong 151
Santa Clara 101
New York 72
The Dalles 70
Munich 69
Boardman 68
Jacksonville 60
Moscow 55
Los Angeles 48
L’Aquila 45
Ho Chi Minh City 35
Hanoi 33
Helsinki 32
Beijing 29
Princeton 29
São Paulo 29
Lawrence 28
Council Bluffs 26
Turku 26
Brno 22
Wilmington 21
Bremen 20
Columbus 20
Des Moines 20
Kitzingen 20
San Mateo 19
Frankfurt am Main 18
Tokyo 18
Rome 17
Warsaw 17
Lappeenranta 15
Brussels 14
Lauterbourg 14
Casoria 13
Johannesburg 13
Stockholm 13
Chennai 12
Atlanta 10
Orem 10
Da Nang 9
Fremont 9
Assago 8
Brooklyn 8
Ann Arbor 7
Denver 7
Falkenstein 7
London 7
San Francisco 7
Shanghai 7
Woodbridge 7
Boston 6
Chicago 6
Dong Ket 6
Haiphong 6
Manchester 6
Mexico City 6
Montevideo 6
Montreal 6
Norwalk 6
Poplar 6
Campinas 5
Jakarta 5
Milan 5
Porto Alegre 5
Recife 5
Turin 5
Amsterdam 4
Curitiba 4
Edinburgh 4
Fortaleza 4
Houston 4
Nuremberg 4
Providence 4
Seoul 4
Sofia 4
Tashkent 4
Washington 4
Ankara 3
Brasília 3
Bến Tre 3
Cedar Knolls 3
Cuiabá 3
Erbil 3
Hải Dương 3
Ipatinga 3
Juneau 3
Mariglianella 3
Marseille 3
Pescara 3
Phoenix 3
Querétaro 3
Raleigh 3
Salvador 3
Seattle 3
Totale 3.233
Nome #
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 160
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 153
Emerging role of isomirs in cancer: State of the art and recent advances 152
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 150
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 143
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 141
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 140
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 137
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 135
Contribution of MUTYH variants to male breast cancer risk: results from a multicenter study in Italy 135
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 132
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 130
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 126
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 125
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 117
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 113
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 109
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 109
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 104
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 103
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 101
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 101
449: Gene-specific methylation profiles in male breast cancer 101
Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer 100
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores 91
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene 91
Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers 91
The antiquity of hydrocephalus: the first full palaeo-neuropathological description 87
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 85
Metastases risk in thin cutaneous melanoma: Prognostic value of clinical-pathologic characteristics and mutation profile 85
Proffered papers and posters presented at the Sixth International Symposium on Hereditary Breast and Ovarian Cancer— BRCA: Challenges and Opportunities 83
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 82
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122 82
MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas 81
Methylome profiling of BRCA-positive and BRCA-negative MBCs 80
CD44 mRNA expression in hormonally treated and non-treated prostate cancer cases 79
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy 79
A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy 79
Smoking and FGFR2 rs2981582 variant independently modulate male breast cancer survival: A population-based study in Tuscany, Italy 73
EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations 73
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance 73
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 70
Evaluation of cyp17a1 and cyp1b1 polymorphisms in male breast cancer risk 70
PIK3CA c.3140A>G mutation in a patient with suspected Proteus Syndrome: a case report 67
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in Italy 66
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 65
Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers 55
null 5
Totale 4.809
Categoria #
all - tutte 19.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.642


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 42 9
2021/2022143 0 4 0 1 24 1 5 8 13 3 9 75
2022/2023685 38 52 18 76 48 81 3 39 281 3 37 9
2023/2024281 19 9 21 7 13 79 1 37 2 18 9 66
2024/20251.144 34 23 74 55 128 93 156 130 151 104 111 85
2025/20262.420 136 235 387 303 260 120 325 80 224 350 0 0
Totale 4.809